Microfluidic two-tissue platform for combined drug efficacy and toxicity testing

• Unité de recherche: INNOSUISSE
• Numéro de projet: 18024.1 PFLS-LS
• Titre du projet anglais: Microfluidic two-tissue platform for combined drug efficacy and toxicity testing

Description succincte (Allemand)

Microfluidic two-tissue platform for combined drug efficacy and toxicity testing

Description succincte (Anglais)

Microfluidic two-tissue platform for combined drug efficacy and toxicity testing

Résumé des résultats (Abstract) (Allemand)

Development and commercialization of an end-user validated microphysiological testing platform for combined drug efficacy and toxicity testing. The platform will rely on microfluidics technology and will enable to metabolically interconnect active human 3D liver microtissues with microtissue tumor models. Handling, operation and read-out will be made compatible with cell culturing standards.

Résumé des résultats (Abstract) (Anglais)

Development and commercialization of an end-user validated microphysiological testing platform for combined drug efficacy and toxicity testing. The platform will rely on microfluidics technology and will enable to metabolically interconnect active human 3D liver microtissues with microtissue tumor models. Handling, operation and read-out will be made compatible with cell culturing standards.